These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2998429)

  • 41. Pharmacological profiles of a potential LTB4-antagonist, SM-9064.
    Namiki M; Igarashi Y; Sakamoto K; Nakamura T; Koga Y
    Biochem Biophys Res Commun; 1986 Jul; 138(2):540-6. PubMed ID: 3017332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study of the photodegradation of leukotriene B4 by ultraviolet irradiation (UVB, UVA).
    Millar B; Green C; Ferguson J; Raffle EJ; Macleod TM
    Br J Dermatol; 1989 Feb; 120(2):145-52. PubMed ID: 2538137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric quantification of T6-positive cells in psoriatic epidermis after PUVA and methotrexate therapy.
    Gommans JM; van Hezik SJ; van Huystee BE
    Br J Dermatol; 1987 May; 116(5):661-6. PubMed ID: 3496110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
    Chang A; van de Kerkhof PC
    Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inhibitory effect of methotrexate on PAF-induced neutrophil and eosinophil locomotion in asthmatic patients.
    Tsai JJ; Wang TF; Wang SR
    Asian Pac J Allergy Immunol; 1994 Jun; 12(1):65-71. PubMed ID: 7872994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate.
    Dos Santos C; Davidson D
    Pediatr Res; 1993 Mar; 33(3):242-6. PubMed ID: 8384710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.
    Brain S; Camp R; Dowd P; Black AK; Greaves M
    J Invest Dermatol; 1984 Jul; 83(1):70-3. PubMed ID: 6330213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of selenium deficiency on caprine polymorphonuclear leukocyte production of leukotriene B4 and its neutrophil chemotactic activity.
    Aziz E; Klesius PH
    Am J Vet Res; 1986 Feb; 47(2):426-8. PubMed ID: 3006557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.
    Guillot B; Coupe M; Alirezai M; Bureau JP; Guilhou JJ
    Arch Dermatol Res; 1989; 280(8):477-80. PubMed ID: 2645836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraepidermal accumulation of polymorphonuclear leukocytes in chronic stable plaque psoriasis.
    van de Kerkhof PC; Lammers AM
    Dermatologica; 1987; 174(5):224-7. PubMed ID: 3582707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Areca nut extracts-activated secretion of leukotriene B4, and phosphorylation of p38 mitogen-activated protein kinase and elevated intracellular calcium concentrations in human polymorphonuclear leukocytes.
    Hung SL; Lin YJ; Chien EJ; Liu WG; Chang HW; Liu TY; Chen YT
    J Periodontal Res; 2007 Oct; 42(5):393-401. PubMed ID: 17760816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.
    Lawrence RH; Sorrelli TC
    Clin Exp Immunol; 1992 Aug; 89(2):321-4. PubMed ID: 1322257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients.
    O'Callaghan JW; Forrest MJ; Brooks PM
    Rheumatol Int; 1988; 8(1):41-5. PubMed ID: 3363283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukotriene B4: a highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes.
    Malmsten CL; Palmblad J; Udén AM; Rådmark O; Engstedt L; Samuelsson B
    Acta Physiol Scand; 1980 Dec; 110(4):449-51. PubMed ID: 6263048
    [No Abstract]   [Full Text] [Related]  

  • 56. Rat ultraviolet ray B photodermatitis: an experimental model of psoriasis vulgaris.
    Nakaguma H; Kambara T; Yamamoto T
    Int J Exp Pathol; 1995 Feb; 76(1):65-73. PubMed ID: 7734340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.
    Ford-Hutchinson AW; Bray MA; Doig MV; Shipley ME; Smith MJ
    Nature; 1980 Jul; 286(5770):264-5. PubMed ID: 6250050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study.
    Bjerring P; Beck HI; Zachariae H; Søgaard H
    Acta Derm Venereol; 1986; 66(6):515-9. PubMed ID: 2433872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A chemotaxis assay using human polymorphonuclear leukocytes stimulated by IL-1.
    Maloff BL; Shaw JE; Fox D
    J Immunol Methods; 1988 Aug; 112(1):145-6. PubMed ID: 2841375
    [No Abstract]   [Full Text] [Related]  

  • 60. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
    Hopkins NK; Schaub RG; Gorman RR
    Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.